Orphan Drugs in 2016
The FDA Law Blog posted an informative article yesterday sharing insight into the status of the orphan drug landscape last year. In 2016, both orphan drug approvals and designations decreased slightly; however, the number of orphan drug designation requests skyrocketed. 2016 was still the second best year for orphan drug designations, and the third best year for orphan drug approvals since the enactment of the Orphan Drug Act.
For a full analysis of designations, approvals, and requests, read the full article here: http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2017/01/orphan-drug-approvals-and-designations-dipped-slightly-in-2016-but-orphan-drug-designation-requests-.html